» Articles » PMID: 19302476

CXCL12 Increases Human Neural Progenitor Cell Proliferation Through Akt-1/FOXO3a Signaling Pathway

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2009 Mar 24
PMID 19302476
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

CXCL12, a ligand for the chemokine receptor CXCR4, is well known in mediating neural progenitor cell (NPC) migration during neural development. However, the effects of CXCL12 on human NPC proliferation and its associated signaling pathways remain unclear. The transcription factor, FOXO3a, a downstream target of Akt-1, is critical for cell cycle control and may also play an important role in regulating NPC proliferation. In this study, we found that CXCL12 promotes human NPC proliferation as determined by the proliferation marker Ki67 and BrdU incorporation. This CXCL12-mediated NPC proliferation was associated with an increase in Akt-1 and FOXO3a phosphorylation in a time- and dose-dependent manner. The CXCR4 antagonist (T140) or inhibitors for G proteins (Pertussis toxin) and phosphoinositide 3-kinase (PI3K) (LY294002) abolished CXCL12-mediated NPC proliferation and phosphorylation of Akt-1 and FOXO3a. The roles of Akt-1 and FOXO3a in CXCL12-mediated NPC proliferation were further investigated by using adenoviral over-expression in NPCs. Over-expression of dominant-negative Akt-1 or wild-type FOXO3a in NPC abrogated CXCL12-mediated proliferation. These data suggest that CXCL12-mediated NPC proliferation is reliant upon the phosphorylation of Akt-1 and FOXO3a and gives insight to an essential role of CXCL12 in neurogenesis. Understanding this mechanism may facilitate the development of novel therapeutic targets for NPC proliferation during neurogenesis.

Citing Articles

Post-stroke hippocampal neurogenesis is impaired by microvascular dysfunction and PI3K signaling in cerebral amyloid angiopathy.

Osborne O, Daftari M, Naranjo O, Johar A, Brooks S, Colbert B Cell Rep. 2024; 43(10):114848.

PMID: 39392753 PMC: 11562893. DOI: 10.1016/j.celrep.2024.114848.


Microglia in physiological conditions and the importance of understanding their homeostatic functions in the arcuate nucleus.

Guzman-Ruiz M, Guerrero Vargas N, Ramirez-Carreto R, Gonzalez-Orozco J, Torres-Hernandez B, Valle-Rodriguez M Front Immunol. 2024; 15:1392077.

PMID: 39295865 PMC: 11408222. DOI: 10.3389/fimmu.2024.1392077.


The role of Foxo3a in neuron-mediated cognitive impairment.

Liu Q, Wu G, Wang X, Xiong X, Rui-Wang , Yao B Front Mol Neurosci. 2024; 17:1424561.

PMID: 38962803 PMC: 11220205. DOI: 10.3389/fnmol.2024.1424561.


The journey of a generation: advances and promises in the study of primordial germ cell migration.

Barton L, Roa-de la Cruz L, Lehmann R, Lin B Development. 2024; 151(7).

PMID: 38607588 PMC: 11165723. DOI: 10.1242/dev.201102.


Utility of the Zebrafish Model for Studying Neuronal and Behavioral Disturbances Induced by Embryonic Exposure to Alcohol, Nicotine, and Cannabis.

Collier A, Abdulai A, Leibowitz S Cells. 2023; 12(20).

PMID: 37887349 PMC: 10605371. DOI: 10.3390/cells12202505.


References
1.
Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers W . Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000; 20(23):8969-82. PMC: 86551. DOI: 10.1128/MCB.20.23.8969-8982.2000. View

2.
Cui M, Huang Y, Zhao Y, Zheng J . Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages. J Immunol. 2008; 180(2):898-906. PMC: 2276663. DOI: 10.4049/jimmunol.180.2.898. View

3.
Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S . Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol. 2000; 64(5):323-32. DOI: 10.1034/j.1600-0609.2000.90147.x. View

4.
Fu Z, Tindall D . FOXOs, cancer and regulation of apoptosis. Oncogene. 2008; 27(16):2312-9. PMC: 2819403. DOI: 10.1038/onc.2008.24. View

5.
Maiese K, Chong Z, Shang Y . "Sly as a FOXO": new paths with Forkhead signaling in the brain. Curr Neurovasc Res. 2007; 4(4):295-302. PMC: 2570708. DOI: 10.2174/156720207782446306. View